Nordea Investment Management
FOLD

Nordea Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Nordea Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-997,780
Closed -$7.84M – 869
2025
Q3 		$7.84M Buy
+997,780
New +$7.1M 0.01% 493
2023
Q1 		– Sell
-648,280
Closed -$7.77M – 963
2022
Q4 		$7.77M Sell
648,280
-4,296
-0.7% -$48.4K 0.01% 427
2022
Q3 		$6.91M Sell
652,576
-43,126
-6% -$481K 0.01% 440
2022
Q2 		$7.38M Sell
695,702
-85,610
-11% -$705K 0.01% 436
2022
Q1 		$7.67M Buy
781,312
+46,124
+6% +$432K 0.01% 483
2021
Q4 		$8.67M Sell
735,188
-8,358
-1% -$93.1K 0.01% 442
2021
Q3 		$7.35M Sell
743,546
-7,897
-1% -$80.8K 0.01% 501
2021
Q2 		$7.24M Buy
+751,443
New +$7.33M 0.01% 501

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nordea Investment Management's FOLD Position: Q4 2025 in Review

Nordea Investment Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 997,780 shares — an estimated $7.84M sold.

Nordea Investment Management first reported a position in FOLD in Q2 2021 and held it in 8 quarters. The position peaked at $8.67M in Q4 2021. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Nordea Investment Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Nordea Investment Management sold 997,780 Amicus Therapeutics shares in Q4 2025, an estimated $7.84M.
  • Nordea Investment Management first reported a position in Amicus Therapeutics in Q2 2021 and held it in 8 quarters.
  • Nordea Investment Management's Amicus Therapeutics position peaked at $8.67M in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Nordea Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.